OncoCyte Corporation (OCX)
NASDAQ: OCX
· Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM
OncoCyte Fail-to-Deliver
Total FTD Shares
22.03K
Below Average
FTD / Avg. Volume
28.96%
High Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jun 18, 2025,
OncoCyte Corporation has
22,027
shares failed to deliver, representing 28.96%
of the average daily volume of
76,061
shares. Over the past year, the monthly average FTD is
4,677
shares, with the current level 371% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 18, 2025 | 3.16 | 22.03K | +3633.39% |
| May 22, 2025 | 3.44 | 590 | -55.34% |
| Apr 25, 2025 | 3.44 | 1.32K | +9.35% |
| Mar 28, 2025 | 3.21 | 1.21K | +8.93% |
| Feb 27, 2025 | 2.57 | 1.11K | +639.33% |
| Jan 28, 2025 | 2.03 | 150 | -90.37% |
| Dec 30, 2024 | 2.45 | 1.56K | +945.64% |
| Nov 25, 2024 | 2.64 | 149 | +964.29% |
| Oct 04, 2024 | 2.89 | 14 | +133.33% |
| Sep 17, 2024 | 3.11 | 6 | -99.91% |
| Aug 14, 2024 | 3.02 | 7.05K | +404.29% |
| Jul 25, 2024 | 3.36 | 1.4K | +39.62% |
| Jun 28, 2024 | 2.95 | 1K | +153.03% |
| May 31, 2024 | 2.74 | 396 | -46.27% |
| Apr 30, 2024 | 2.49 | 737 | -76.82% |
| Mar 25, 2024 | 3.02 | 3.18K | +280.38% |
| Feb 26, 2024 | 3.05 | 836 | -19.38% |
| Jan 26, 2024 | 3.13 | 1.04K | +94.19% |
| Dec 19, 2023 | 2.86 | 534 | +775.41% |
| Nov 30, 2023 | 3.8 | 61 | +90.63% |
| Oct 11, 2023 | 3.15 | 32 | -53.62% |
| Sep 29, 2023 | 3.12 | 69 | +392.86% |
| Aug 14, 2023 | 3.42 | 14 | -99.13% |
| Jul 31, 2023 | 4.17 | 1.61K | -97.83% |
| Jun 30, 2023 | 4.6 | 74.03K | +21931.25% |
| May 31, 2023 | 4.28 | 336 | +37.14% |
| Apr 21, 2023 | 5.4 | 245 | -66.98% |
| Mar 31, 2023 | 7.08 | 742 | -38.42% |
| Feb 17, 2023 | 8.2 | 1.21K | -27.41% |
| Jan 26, 2023 | 8.8 | 1.66K | n/a |